SEARCH

SEARCH BY CITATION

References

  • 1
    Simon D, Simon HU. Eosinophilic disorders. J Allergy Clin Immunol 2007;119:12911300.
  • 2
    Simon D, Wardlaw A, Rothenberg ME. Organ-specific eosinophilic disorders of the skin, lung, and gastrointestinal tract. J Allergy Clin Immunol 2010;126:313.
  • 3
    Klion AD, Nutman TB. The role of eosinophils in host defense against helminth parasites. J Allergy Clin Immunol 2004;113:3037.
  • 4
    Frigas E, Motojima S, Gleich GJ. The eosinophilic injury to the mucosa of the airways in the pathogenesis of bronchial asthma. Eur Respir J 1991;13:S123S135.
  • 5
    Jacobsen EA, Taranova AG, Lee NA, Lee JJ. Eosinophils: singularly destructive effector cells or purveyors of immunoregulation. J Allergy Clin Immunol 2007;119:13131320.
  • 6
    Yousefi S, Gold JA, Andina N, Lee JJ, Kelly AM, Kozlowski E et al. Catapult-like release of mitochondrial DNA by eosinophils contributes to antibacterial defense. Nat Med 2008;14:949953.
  • 7
    Simon D, Hoesli S, Roth N, Staedler S, Yousefi S, Simon HU. Eosinophil extracellular DNA traps in skin diseases. J Allergy Clin Immunol 2011;127:194199.
  • 8
    Wong DT, Elovic A, Matossian K, Nagura N, McBride J, Chou MY et al. Eosinophils from patients with blood eosinophilia express transforming growth factor beta 1. Blood 1991;78:27022707.
  • 9
    Nakajima H, Gleich GJ, Kita H. Constitutive production of IL-4 and IL-10 and stimulated production of IL-8 by normal peripheral blood eosinophils. J Immunol 1996;156:48594866.
  • 10
    Phipps S, Ying S, Wangoo A, Ong YE, Levi-Schaffer F, Kay AB. The relationship between allergen-induced tissue eosinophilia and markers of repair and remodeling in human atopic skin. J Immunol 2002;169:46044612.
  • 11
    Puxeddu I, Bader R, Piliponsky AM, Reich R, Levi-Schaffer F, Berkman N. The CC chemokine eotaxin/CCL11 has a selective profibrogenic effect on lung fibroblasts. J Allergy Clin Immunol 2006;117:103110.
  • 12
    Iwamoto I, Nakajima H, Endo H, Yoshida S. Interferon gamma regulates antigen-induced eosinophil recruitment into the mouse airways by inhibiting the infiltration of CD4+ T cells. J Exp Med 1993;177:573576.
  • 13
    Horie S, Okubo Y, Hossain M, Sato E, Nomura H, Koyama S et al. Interleukin-13 but not interleukin-4 prolongs eosinophil survival and induces eosinophil chemotaxis. Intern Med 1997;36:179185.
  • 14
    Wong CK, Hu S, Cheung PF, Lam CW. Thymic stromal lymphopoietin induces chemotactic and prosurvival effects in eosinophils: implications in allergic inflammation. Am J Respir Cell Mol Biol 2010;43:305315.
  • 15
    Cherry WB, Yoon J, Bartemes KR, Iijima K, Kita H. A novel IL-1 family cytokine, IL-33, potently activates human eosinophils. J Allergy Clin Immunol 2008;121:14841490.
  • 16
    Bulek K, Swaidani S, Aronica M, Li X. Epithelium: the interplay between innate and Th2 immunity. Immunol Cell Biol 2010;88:257268.
  • 17
    Simon HU, Yousefi S, Schranz C, Schapowal A, Bachert C, Blaser K. Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia. J Immunol 1997;158:39023908.
  • 18
    Huang CD, Wang CH, Liu CY, Lin SM, Chou CL, Liu WT et al. Eosinophils from asthmatics release IL-5 in an autocrine fashion to prevent apoptosis through upregulation of Bcl-2 expression. J Asthma 2005;42:395403.
  • 19
    Schmid-Grendelmeier P, Altznauer F, Fischer B, Bizer C, Straumann A, Menz G et al. Eosinophils express functional IL-13 in eosinophilic inflammatory diseases. J Immunol 2002;169:10211027.
  • 20
    Simon D, Vassina E, Yousefi S, Kozlowski E, Braathen LR, Simon HU. Reduced dermal infiltration of cytokine-expressing inflammatory cells in atopic dermatitis after short-term topical tacrolimus treatment. J Allergy Clin Immunol 2004;114:887895.
  • 21
    Wang YH, Angkasekwinai P, Lu N, Voo KS, Arima K, Hanabuchi S et al. IL-25 augments type 2 immune responses by enhancing the expansion and functions of TSLP-DC-activated Th2 memory cells. J Exp Med 2007;204:18371847.
  • 22
    Petkovic V, Moghini C, Paoletti S, Uguccioni M, Gerber B. Eotaxin-3/CCL26 is a natural antagonist for CC chemokine receptors 1 and 5. A human chemokine with a regulatory role. J Biol Chem 2004;279:2335723363.
  • 23
    Nakayama T, Watanabe Y, Oiso N, Higuchi T, Shigeta A, Mizuguchi N et al. Eotaxin-3/CC chemokine ligand 26 is a functional ligand for CX3CR1. J Immunol 2010;185:64726479.
  • 24
    Toda M, Leung DY, Molet S, Boguniewicz M, Taha R, Christodoulopoulos P et al. Polarized in vivo expression of IL-11 and IL-17 between acute and chronic skin lesions. J Allergy Clin Immunol 2003;111:875881.
  • 25
    Minshall E, Chakir J, Laviolette M, Molet S, Zhu Z, Olivenstein R et al. IL-11 expression is increased in severe asthma: association with epithelial cells and eosinophils. J Allergy Clin Immunol 2000;105:232238.
  • 26
    Flood-Page P, Menzies-Gow A, Phipps S, Ying S, Wangoo A, Ludwig MS et al. Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics. J Clin Invest 2003;112:10291036.
  • 27
    Straumann A, Conus S, Grzonka P, Kita H, Kephart G, Bussmann C et al. Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial. Gut 2010;59:2130.
  • 28
    Giomi B, Caproni M, Calzolari A, Bianchi B, Fabbri P. bTh1, Th2 and Th3 cytokines in the pathogenesis of bullous pemphigoid. J Dermatol Sci 2002;30:116128.
  • 29
    Smith AD, Bagheri B, Streilein RD, Hall RP III. Expression of interleukin-4 and interferon-gamma in the small bowel of patients with dermatitis herpetiformis and isolated gluten-sensitive enteropathy. Dig Dis Sci 1999;44:21242132.
  • 30
    Soumelis V, Reche PA, Kanzler H, Yuan W, Edward G, Homey B et al. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat Immunol 2002;3:673680.
  • 31
    Shimanovich I, Mihai S, Oostingh GJ, Ilenchuk TT, Bröcker EB, Opdenakker G et al. Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid. J Pathol 2004;204:519527.
  • 32
    Lim DH, Cho JY, Miller M, McElwain K, McElwain S, Broide DH. Reduced peribronchial fibrosis in allergen-challenged MMP-9-deficient mice. Am J Physiol Lung Cell Mol Physiol 2006;291:265271.
  • 33
    Titus RG, Sherry B, Cerami A. Tumor necrosis factor plays a protective role in experimental murine cutaneous leishmaniasis. J Exp Med 1989;170:20972104.
  • 34
    Broide DH, Paine MM, Firestein GS. Eosinophils express interleukin 5 and granulocyte macrophage-colony-stimulating factor mRNA at sites of allergic inflammation in asthmatics. J Clin Invest 1992;90:14141424.
  • 35
    Kohan M, Puxeddu I, Reich R, Levi-Schaffer F, Berkman N. Eotaxin-2/CCL24 and eotaxin-3/CCL26 exert differential profibrogenic effects on human lung fibroblasts. Ann Allergy Asthma Immunol 2010;104:6672.
  • 36
    Dasu MR, Hawkins HK, Barrow RE, Xue H, Herndon DN. Gene expression profiles from hypertrophic scar fibroblasts before and after IL-6 stimulation. J Pathol 2004;202:476485.
  • 37
    Miyagaki T, Sugaya M, Fujita H, Ohmatsu H, Kakinuma T, Kadono T et al. Eotaxins and CCR3 interaction regulates the Th2 environment of cutaneous T-cell lymphoma. J Invest Dermatol 2010;130:23042311.
  • 38
    Jundt F, Anagnostopoulos I, Bommert K, Emmerich F, Müller G, Foss HD et al. Hodgkin/Reed-Sternberg cells induce fibroblasts to secrete eotaxin, a potent chemoattractant for T cells and eosinophils. Blood 1999;94:20652071.
  • 39
    Cheadle EJ, Riyad K, Subar D, Rothwell DG, Ashton G, Batha H et al. Eotaxin-2 and colorectal cancer: a potential target for immune therapy. Clin Cancer Res 2007;13:57195728.
  • 40
    Kleinhans M, Tun-Kyi A, Gilliet M, Kadin ME, Dummer R, Burg G et al. Functional expression of the eotaxin receptor CCR3 in CD30+ cutaneous T-cell lymphoma. Blood 2003;101:14871493.
  • 41
    Aldinucci D, Lorenzon D, Olivo K, Rapanà B, Gattei V. Interactions between tissue fibroblasts in lymph nodes and Hodgkin/Reed-Sternberg cells. Leuk Lymphoma 2004;45:17311739.
  • 42
    Yang L, Pang Y, Moses HL. TGF-beta and immune cells: an important regulatory axis in the tumor microenvironment and progression. Trends Immunol 2010;31:220227.
  • 43
    Maniati E, Soper R, Hagemann T. Up for Mischief? IL-17/Th17 in the tumour microenvironment Oncogene 2010;29:56535662.
  • 44
    Straumann A, Kristl J, Conus S, Vassina E, Spichtin HP, Beglinger C et al. Cytokine expression in healthy and inflamed mucosa: probing the role of eosinophils in the digestive tract. Inflamm Bowel Dis 2005;11:720726.